Evidence map›Paper›PMID 36994769›Full record

ArticleComprehensive Physiology2023

Aldosterone: Renal Action and Physiological Effects.

Jermaine G Johnston, Amanda K Welch, Brian D Cain, Peter P Sayeski, Michelle L Gumz, Charles S Wingo

Open access · hybridAbstract read
In one paragraph

Article in Comprehensive Physiology, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 20 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
20citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

20 citing papers in PubMed, 1 synthesis or guideline pooled it, 15 citations in OpenAlex.

  1. Pooled it
  2. Trial
  3. Renalase stimulates aldosterone production via PMCA4b/cAMP in NCI-H295R cells.Journal of enzyme inhibition and medicinal chemistry · 2026
    Article
  4. Review
  5. Article
  6. How Does Dietary Potassium Influence BP?Journal of the American Society of Nephrology : JASN · 2026
    Review
  7. Review
  8. Review
  9. Potassium-Rich, Gluten-Free Diets for Patients with Sjögren's Syndrome: A Mini-ReviewEndocrine, metabolic & immune disorders drug targets · 2026
    Review
  10. Review
  11. Article
  12. Review
  13. The potential for improving cardio-renal outcomes in chronic kidney disease with the aldosterone synthase inhibitor vicadrostat (BI 690517): a rationale for the EASi-KIDNEY trial.Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association · 2025
    Article
  14. Epithelial Na+ Channels, Immune Cells, and Salt.Annual review of physiology · 2025
    Review
  15. Article
  16. Mineralocorticoid Receptor and Sleep Quality in Chronic Kidney Disease.International journal of molecular sciences · 2024
    Review
  17. Review
  18. Review
  19. Adverse Effects of Aldosterone: Beyond Blood Pressure.Journal of the American Heart Association · 2024
    Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 1 institution in 1 country.

Jermaine G JohnstonDivision of Nephrology, Hypertension and Renal Transplantation, Department of Medicine, University of Florida, Gainesville, Florida, USA.
Amanda K WelchDivision of Nephrology, Hypertension and Renal Transplantation, Department of Medicine, University of Florida, Gainesville, Florida, USA.
Brian D CainDepartment of Biochemistry and Molecular Biology, University of Florida, Gainesville, Florida, USA.
Peter P SayeskiDepartment of Physiology and Functional Genomics, University of Florida, Gainesville, Florida, USA.
Michelle L GumzDivision of Nephrology, Hypertension and Renal Transplantation, Department of Medicine, University of Florida, Gainesville, Florida, USA.
Charles S WingoDivision of Nephrology, Hypertension and Renal Transplantation, Department of Medicine, University of Florida, Gainesville, Florida, USA.
University of Florida · US

Funding

Per1 and the kidney clock in hypertensionR01DK109570 · NIDDK · UNIVERSITY OF FLORIDA · PI GUMZ, MICHELLE L · 2017 to 2021
$1.5M
Modulation of the renal aldosterone endothelin feedback system by the clock protein PER1R56DK128271 · NIDDK · UNIVERSITY OF FLORIDA · PI GUMZ, MICHELLE L, WINGO, CHARLES S · 2021 to 2021
$100k
NIDDK NIH HHS R01 DK109570NIDDK NIH HHS R56 DK128271
6 · The paper itself

Abstract

Aldosterone exerts profound effects on renal and cardiovascular physiology. In the kidney, aldosterone acts to preserve electrolyte and acid-base balance in response to changes in dietary sodium (Na

Indexed as

AldosteroneKidneyBlood PressureHumansNephronsSodiumAldosteroneSodium

Identifiers

PMID36994769
PMCPMC11472823
OpenAlexW4361270566

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.